Dosidal · Switzerland
Ruxolitinib Sandoz, Tabletten
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:70733 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 70733 atc: L01EJ01 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2026-05-04 term: zugelassen valid_until: 2031-05-03 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: L01EJ01 authorisation_number: 70733 form: TAB holder: Sandoz Pharmaceuticals AG holder_partner_nr: 1006431 it_number: 07.16.1. name: Ruxolitinib Sandoz, Tabletten state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53b4XVGzssZUrujGGPBOZ6uj2uM8Ekmn1d0Wlo3DQB4lLsAPFU7zLKIs7lVzZgoehOlA832AbJ5KwJ03Ub6s29EwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |